These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37944388)

  • 1. Novel family of [RuCp(N,N)(P)]
    Teixeira RG; Mészáros JP; Matos B; Côrte-Real L; Xavier CPR; Fontrodona X; Garcia MH; Romero I; Spengler G; Vasconcelos MH; Tomaz AI; Enyedy ÉA; Valente A
    Eur J Med Chem; 2023 Dec; 262():115922. PubMed ID: 37944388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organometallic Ru(II), Rh(III) and Re(I) complexes of sterane-based bidentate ligands: synthesis, solution speciation, interaction with biomolecules and anticancer activity.
    Pivarcsik T; Kiss MA; Rapuš U; Kljun J; Spengler G; Frank É; Turel I; Enyedy ÉA
    Dalton Trans; 2024 Mar; 53(11):4984-5000. PubMed ID: 38406993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel "ruthenium cyclopentadienyl"-peptide conjugate complexes against human FGFR(+) breast cancer.
    Franco Machado J; Machuqueiro M; Marques F; Robalo MP; Piedade MFM; Garcia MH; Correia JDG; Morais TS
    Dalton Trans; 2020 May; 49(18):5974-5987. PubMed ID: 32314752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological properties of tetranuclear ruthenium complexes containing the bis[4(4'-methyl-2,2'-bipyridyl)]-1,7-heptane ligand.
    Sun B; Sundaraneedi MK; Southam HM; Poole RK; Musgrave IF; Keene FR; Collins JG
    Dalton Trans; 2019 Oct; 48(38):14505-14515. PubMed ID: 31531475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, HSA/DNA interactions and antitumor activity of new [Ru(η
    Đukić MB; Jeremić MS; Filipović IP; Klisurić OR; Kojić VV; Jakimov DS; Jelić RM; Onnis V; Matović ZD
    J Inorg Biochem; 2020 Dec; 213():111256. PubMed ID: 32980642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the antibacterial and anticancer potential of tryptamine based mixed ligand Schiff base Ruthenium(III) complexes.
    Malik MA; Raza MK; Dar OA; Amadudin ; Abid M; Wani MY; Al-Bogami AS; Hashmi AA
    Bioorg Chem; 2019 Jun; 87():773-782. PubMed ID: 30974300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.
    Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA
    J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heteroleptic mononuclear compounds of ruthenium(ii): synthesis, structural analyses, in vitro antitumor activity and in vivo toxicity on zebrafish embryos.
    Lenis-Rojas OA; Fernandes AR; Roma-Rodrigues C; Baptista PV; Marques F; Pérez-Fernández D; Guerra-Varela J; Sánchez L; Vázquez-García D; Torres ML; Fernández A; Fernández JJ
    Dalton Trans; 2016 Dec; 45(47):19127-19140. PubMed ID: 27868117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
    Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
    Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazolone incorporating bipyridyl metallointercalators as effective DNA, protein and lung cancer targets: Synthesis, characterization and in vitro biocidal evaluation.
    Vyas KM; Devkar RV; Prajapati A; Jadeja RN
    Chem Biol Interact; 2015 Oct; 240():250-66. PubMed ID: 26341650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methyl-cyclopentadienyl Ruthenium Compounds with 2,2'-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential.
    Côrte-Real L; Teixeira RG; Gírio P; Comsa E; Moreno A; Nasr R; Baubichon-Cortay H; Avecilla F; Marques F; Robalo MP; Mendes P; Ramalho JPP; Garcia MH; Falson P; Valente A
    Inorg Chem; 2018 Apr; 57(8):4629-4639. PubMed ID: 29611696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative solution equilibrium and structural studies of half-sandwich ruthenium(II)(η
    Poljarević JM; Tamás Gál G; May NV; Spengler G; Dömötör O; Savić AR; Grgurić-Šipka S; Enyedy ÉA
    J Inorg Biochem; 2018 Apr; 181():74-85. PubMed ID: 29407910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unprecedented inhibition of P-gp activity by a novel ruthenium-cyclopentadienyl compound bearing a bipyridine-biotin ligand.
    Côrte-Real L; Karas B; Gírio P; Moreno A; Avecilla F; Marques F; Buckley BT; Cooper KR; Doherty C; Falson P; Garcia MH; Valente A
    Eur J Med Chem; 2019 Feb; 163():853-863. PubMed ID: 30579125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: Ranging from non-cytotoxic to highly cytotoxic compounds.
    Côrte-Real L; Robalo MP; Marques F; Nogueira G; Avecilla F; Silva TJ; Santos FC; Tomaz AI; Garcia MH; Valente A
    J Inorg Biochem; 2015 Sep; 150():148-59. PubMed ID: 26150132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition.
    Teixeira RG; Salaroglio IC; Oliveira NFB; Sequeira JGN; Fontrodona X; Romero I; Machuqueiro M; Tomaz AI; Garcia MH; Riganti C; Valente A
    J Med Chem; 2023 Oct; 66(20):14080-14094. PubMed ID: 37616241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes.
    Lazić D; Arsenijević A; Puchta R; Bugarčić ŽD; Rilak A
    Dalton Trans; 2016 Mar; 45(11):4633-46. PubMed ID: 26855406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
    Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
    Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionic mononuclear [Fe] and heterodinuclear [Fe,Ru] bis(diphenylphosphino)alkane complexes: Synthesis, spectroscopy, DFT structures, cytotoxicity, and biomolecular interactions.
    Odachowski M; Neven R; Perversi G; Romano D; Slabber CA; Hadiji M; Honing M; Zhao Y; Munro OQ; Blom B
    J Inorg Biochem; 2023 May; 242():112156. PubMed ID: 36801621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic activity of Ru(II)/DPEPhos/N,S-mercapto complexes (DPEPhos = bis-[(2-diphenylphosphino)phenyl]ether).
    Grawe GF; Oliveira KM; Leite CM; de Oliveira TD; Costa AR; Moraes CAF; Honorato J; Cominetti MR; Castellano EE; Correa RS; Machado SP; Batista AA
    J Inorg Biochem; 2023 Jul; 244():112204. PubMed ID: 37004320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 8-Hydroxyquinoline-Amino Acid Hybrids and Their Half-Sandwich Rh and Ru Complexes: Synthesis, Anticancer Activities, Solution Chemistry and Interaction with Biomolecules.
    Pivarcsik T; Dömötör O; Mészáros JP; May NV; Spengler G; Csuvik O; Szatmári I; Enyedy ÉA
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.